Association between immune-related adverse events and recurrence dynamics under adjuvant anti-PD-1 therapy in resected melanoma
{{output}}
Introduction: Adjuvant anti-PD-1 therapy has significantly improved recurrence-free survival (RFS) in patients with resected high-risk melanoma, yet a substantial proportion still relapse. Identifying predictors of recurrence rem... ...
